Call for Research Proposals

Submission Deadlines – October 15 and April 15

The Angelman Syndrome Foundation conducts biannual calls for research proposals. Applications are accepted on a continual basis, with submission deadlines for subsequent review occurring annually on October 15 and April 15. One- or two-year grants will be awarded for various amounts of up to $100,000 per year.

Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome, translational research and clinical research studies. Of particular interest to the ASF are studies related to communication, behavioral issues and identification of issues and treatments that impact the daily life of people with Angelman syndrome and their families. Researchers from all countries are encouraged to apply.

Information and Instructions for Research Proposal Submission

One- or two-year grants will be awarded for various amounts of up to $100,000 per year. The application will use the ASF research grant submission form and will include the following:

  • Cover page completed including title of proposal and name of principal investigator
  • One-page summary abstract of proposed research
  • Proposal, including hypothesis, background,research plan, and significance of the proposed research; page limits indicated within application
  • Curriculum vitae of the applicant
  • One-page detailed budget o Indirect costs of up to 10% will be allowed (to be included in the total budget amount not to exceed $100,000 per year)
  • Proposals involving human or animal subjects must be approved by institutional review boards before funding is released. Please include approval with proposal if possible.

All proposals, including cover letters, will be submitted in one (1) .pdf file using the ASF Grant Submission Form.

Subject line to read: ASF MM_20XX General RFP Submission (e.g., ASF 10_2018 General RFP Submission)
File name to read: PI’s last name_MM_20XX_Gen_RFP.pdf. (e.g., Smith_10_2018_Gen_RFP.pdf)

Questions should be directed to ASF Scientific Advisory Chair, Stormy Chamberlain, PhD, via ASF at: